A recent study has employed Quantitative Structure-Property Relationship (QSPR) modeling and Multi-Criteria Decision Making (MCDM) to evaluate the ...
A recent study published in Nature explores the long-term effects of high-speed resistance training on older adults, focusing on the rate of torque...
Researchers at the University of Utah have conducted a study on the effects of Ozempic, a popular anti-diabetic and weight-loss drug, on muscle mas...
Research from Swedish cohorts suggests that high coffee consumption may be linked to an increased risk of abdominal aortic aneurysm (AAA) in smoker...
Recent research published in Clinical Neurophysiology suggests that cycling may help restore neural connections damaged by Parkinson's disease, pot...
Celldex Therapeutics, Inc. has reported significant progress in its pipeline, particularly with the development of barzolvolimab, a humanized monoc...
Eli Lilly's oral GLP-1 therapy, orforglipron, has shown promising results in its Phase III ATTAIN-1 study, achieving a 12.4% average weight reducti...
A meta-analysis published in BMC Medicine has found that patients who stop taking weight loss drugs, such as Ozempic, often experience a rebound in...
As weight loss drugs such as Ozempic and Mounjaro gain popularity, concerns have emerged about their potential links to cancer. These drugs, known ...
Eli Lilly has announced promising results from trials of a new daily weight loss pill, orforglipron, which has demonstrated the ability to help pat...